Drug-induced vascular injury--a quest for biomarkers.

[1]  J. Font,et al.  Circulating soluble adhesion molecules in ANCA-associated vasculitis. , 2001, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[2]  N. Cook,et al.  Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events , 2003 .

[3]  H. Baumann,et al.  Acute Phase Proteins , 2020, Encyclopedia of Behavioral Medicine.

[4]  E Holmes,et al.  Chemometric models for toxicity classification based on NMR spectra of biofluids. , 2000, Chemical research in toxicology.

[5]  P. Boor,et al.  Chemical-induced vasculature injury. Summary of the symposium presented at the 32nd annual meeting of the Society of Toxicology, New Orleans, Louisiana, March 1993. , 1995, Toxicology and applied pharmacology.

[6]  D. Vestweber,et al.  Cloning of the mouse endothelial selectins. Expression of both E- and P-selectin is inducible by tumor necrosis factor alpha. , 1992, The Journal of biological chemistry.

[7]  J. Arnal,et al.  Endothelium-derived nitric oxide and vascular physiology and pathology , 1999, Cellular and Molecular Life Sciences CMLS.

[8]  L. Horstman,et al.  Elevated endothelial microparticles in thrombotic thrombocytopenic purpura: findings from brain and renal microvascular cell culture and patients with active disease , 2001, British journal of haematology.

[9]  John C. Lindon,et al.  NMR Spectroscopy of Biofluids , 1999 .

[10]  T Brott,et al.  Phenylpropanolamine and the risk of hemorrhagic stroke. , 2000, The New England journal of medicine.

[11]  P. Kincade,et al.  CD44 and its interaction with extracellular matrix. , 1993, Advances in immunology.

[12]  M. van der Giessen,et al.  Circulating cytomegalovirus (CMV)-infected endothelial cells in patients with an active CMV infection. , 1993, The Journal of infectious diseases.

[13]  M. Karmochkine,et al.  Thrombomodulin: An overview and potential implications in vascular disorders , 1998, Lupus.

[14]  E. Joseph,et al.  Mesenteric Arteriopathy in the Rat Induced by Phosphodiesterase III Inhibitors: An Investigation of Morphological, Ultrastructural, and Hemodynamic Changes , 1996, Toxicologic pathology.

[15]  K. Doi,et al.  Histopathological and immunohistochemical studies on arteritis induced by fenoldopam, a vasodilator, in rats. , 2001, Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie.

[16]  J. Johnson,et al.  Expression of intercellular adhesion molecule-1 (ICAM-1) in the skin of patients with systemic scleroderma. , 1991, The Journal of investigative dermatology.

[17]  K. Stuhlmeier,et al.  Endothelial Cell Activation and Thromboregulation during Xenograft Rejection , 1994, Immunological reviews.

[18]  Donna L Mendrick,et al.  Toxicogenomics: a new revolution in drug safety. , 2002, Drug discovery today.

[19]  Howard M. Shapiro,et al.  Practical Flow Cytometry , 1985 .

[20]  E. Topol,et al.  Prognostic value of myeloperoxidase in patients with chest pain. , 2003, The New England journal of medicine.

[21]  P. Merkel,et al.  DRUG-INDUCED VASCULITES , 2001 .

[22]  R. Berne,et al.  Adenosine in the local regulation of blood flow: a brief overview. , 1983, Federation proceedings.

[23]  T. Vial,et al.  Clinical Toxicity of Cytokines Used As Haemopoietic Growth Factors , 1995, Drug safety.

[24]  C. Stehouwer,et al.  von Willebrand Factor (vWf) as a Plasma Marker of Endothelial Activation in Diabetes: Improved Reliability with Parallel Determination of the vWf Propeptide (vWf:AgII) , 1998, Thrombosis and Haemostasis.

[25]  M. Drab,et al.  Loss of Caveolae, Vascular Dysfunction, and Pulmonary Defects in Caveolin-1 Gene-Disrupted Mice , 2001, Science.

[26]  G. Zbinden,et al.  Cardiotoxicity of vasodilators and positive inotropic/vasodilating drugs in dogs: an overview. , 1992, Critical reviews in toxicology.

[27]  Toshio Hirano,et al.  Recombinant human interleukin‐6 (IL‐6/BSF‐2/HSF) regulates the synthesis of acute phase proteins in human hepatocytes , 1988, FEBS letters.

[28]  P. Snyder,et al.  Interleukin-6 activity in dogs with juvenile polyarteritis syndrome: effect of corticosteroids. , 1995, Clinical immunology and immunopathology.

[29]  Drug-induced vasculitis can be severe , 1994 .

[30]  V. Tesar,et al.  Influence of Plasma Exchange on Serum Levels of Cytokines and Adhesion Molecules in ANCA-Positive Renal Vasculitis , 1998, Blood Purification.

[31]  A. Inomata,et al.  Coronary arterial lesions induced by endothelin antagonists. , 2000, Toxicology letters.

[32]  J. Loscalzo,et al.  Endothelial cells in physiology and in the pathophysiology of vascular disorders. , 1998, Blood.

[33]  K. Doi,et al.  Immunohistochemical study on inducible type of nitric oxide (iNOS), basic fibroblast growth factor (bFGF) and tumor growth factor-beta1 (TGF-beta1) in arteritis induced in rats by fenoldopam and theophylline, vasodilators. , 2002, Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie.

[34]  A. Schwarting,et al.  Cytotoxic effects of antibodies to proteinase 3 (C‐ANCA) on human endothelial cells , 1994, Clinical and experimental immunology.

[35]  Sidney C. Smith,et al.  MARKERS OF INFLAMMATION AND CARDIOVASCULAR DISEASE: APPLICATION TO CLINICAL AND PUBLIC HEALTH PRACTICE: A STATEMENT FOR HEALTHCARE PROFESSIONALS FROM THE CENTERS FOR DISEASE CONTROL AND PREVENTION AND THE AMERICAN HEART ASSOCIATION , 2003 .

[36]  C. Hartley,et al.  Effects of hydralazine on regional blood flow in conscious dogs. , 1986, The Journal of pharmacology and experimental therapeutics.

[37]  R. Clark,et al.  Mast cells are potent regulators of endothelial cell adhesion molecule ICAM‐1 and VCAM‐1 expression , 1995, Journal of cellular physiology.

[38]  Y. Kotelevtsev,et al.  Application of gene expression profiling to cardiovascular disease. , 2002, Cardiovascular research.

[39]  R. Berne.  The role of adenosine in the regulation of coronary blood flow. , 1980, Circulation research.

[40]  D. Williams,et al.  Flow Cytometry in the Preclinical Development of Biopharmaceuticals , 1999, Toxicologic pathology.

[41]  G. Hoffman,et al.  Inflammatory Diseases of Blood Vessels , 2001 .

[42]  K. Meyer zum Büschenfelde,et al.  Human endothelial cells express proteinase 3, the target antigen of anticytoplasmic antibodies in Wegener's granulomatosis. , 1993, Blood.

[43]  R. Bernstein,et al.  Autoantibodies to myeloperoxidase in idiopathic and drug-induced systemic lupus erythematosus and vasculitis. , 1994, British journal of rheumatology.

[44]  T. Uchiyama,et al.  The pathogenesis of Kawasaki disease and superantigens. , 1999, Japanese journal of infectious diseases.

[45]  N. Mounier,et al.  CD95 engagement induces disseminated endothelial cell apoptosis in vivo: immunopathologic implications. , 2002, Blood.

[46]  E Holmes,et al.  Accelerated toxicity screening using NMR and pattern recognition-based methods. , 2000, Current opinion in drug discovery & development.

[47]  H. Dvorak,et al.  Mast Cells Can Secrete Vascular Permeability Factor/ Vascular Endothelial Cell Growth Factor and Exhibit Enhanced Release after Immunoglobulin E–dependent Upregulation of Fcε Receptor I Expression , 1998, The Journal of experimental medicine.

[48]  V. Ferrans,et al.  SK&F 95654-Induced Acute Cardiovascular Toxicity in Sprague-Dawley Rats—Histopathologic, Electron Microscopic, and Immunohistochemical Studies , 2002, Toxicologic pathology.

[49]  Blann Ad.  Endothelial cell activation, injury, damage and dysfunction: separate entities or mutual terms? , 2000 .

[50]  K. Gallagher,et al.  Studies on Coronary Arteriopathy in Dogs Following Administration of CI-1020, an Endothelin A Receptor Antagonist , 2001, Toxicologic pathology.

[51]  M. Albassam,et al.  Coronary Arteriopathy in Monkeys Following Administration of CI-1020, an Endothelin A Receptor Antagonist , 1999, Toxicologic pathology.

[52]  W. Scherbaum,et al.  Interaction of endothelial cells and neutrophils in vitro: kinetics of thrombomodulin, intercellular adhesion molecule‐1 (ICAM‐1), E‐selectin, and vascular cell adhesion molecule‐1 (VCAM‐1): implications for the relevance as serological disease activity markers in vasculitides , 2000, Clinical and experimental immunology.

[53]  M. Nagarkatti,et al.  Evidence for the involvement of Fas ligand and perforin in the induction of vascular leak syndrome. , 1998, Journal of immunology.

[54]  R. Atkins,et al.  Expression of VCAM-1 and E-selectin in an in vivo model of endothelial activation. , 1993, The American journal of pathology.

[55]  L. Tierney,et al.  Endothelin receptor subtype distribution predisposes coronary arteries to damage. , 2000, The American journal of pathology.

[56]  C. Garlanda,et al.  A general strategy for isolation of endothelial cells from murine tissues. Characterization of two endothelial cell lines from the murine lung and subcutaneous sponge implants. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[57]  Bulbul Chakravarti,et al.  Informatic tools for proteome profiling. , 2002, BioTechniques.

[58]  J. Sobota.  Review of Cardiovascular Findings in Humans Treated with Minoxidil 1 , 1989, Toxicologic pathology.

[59]  K. Zoon.  Future Directions in Cancer Research: Impact of the Completion of the Human Genome , 2004, Toxicologic pathology.

[60]  R. Wiltrout,et al.  A method for obtaining and culturing large numbers of purified organ‐derived murine endothelial cells , 1994, Journal of leukocyte biology.

[61]  M. Higgins,et al.  Cardiovascular Alterations in Dogs Treated with Hydralazine , 1987, Toxicologic pathology.

[62]  D. Alcorta,et al.  Microarray Studies of Gene Expression in Circulating Leukocytes in Kidney Diseases , 2002, Nephron Experimental Nephrology.

[63]  T. Shiohara,et al.  Systemic release of interferon-gamma in drug-induced cutaneous vasculitis. , 1992, Lancet.

[64]  J. Ross,et al.  Vascular Gene Discovery Using Laser Capture Microdissection of Human Blood Vessels and Quantitative PCR , 2001, Annals of the New York Academy of Sciences.

[65]  J. Hladovec.  Circulating endothelial cells as a sign of vessel wall lesions. , 1978, Physiologia Bohemoslovaca.

[66]  D. Detweiler,et al.  Spontaneous and Induced Arterial Disease in the Dog: Pathology and Pathogenesis 1 , 1989, Toxicologic pathology.

[67]  D. B. Evans,et al.  The Effect of the Cardiotonic Imazodan (CI‐914) on Myocardial and Peripheral Hemodynamics in the Anesthetized Dog , 1986, Journal of cardiovascular pharmacology.

[68]  Y. Shoenfeld,et al.  Pathogenic role of anti-endothelial cell antibodies in systemic vasculitis. , 2000, Wiener klinische Wochenschrift.

[69]  L. Calabrese,et al.  Drug‐induced vasculitis , 1996, Current opinion in rheumatology.

[70]  I. Pecht,et al.  Mercuric chloride-induced vasculitis in the Brown Norway rat: alpha beta T cell-dependent and -independent phases: role of the mast cell. , 1997, Journal of immunology.

[71]  Harmonization of animal clinical pathology testing in toxicity and safety studies. The Joint Scientific Committee for International Harmonization of Clinical Pathology Testing. , 1996, Fundamental and applied toxicology : official journal of the Society of Toxicology.

[72]  Andreas D. Baxevanis,et al.  Bioinformatics - a practical guide to the analysis of genes and proteins , 2001, Methods of biochemical analysis.

[73]  Vilmundur Gudnason,et al.  C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. , 2004, The New England journal of medicine.

[74]  D. Hochstrasser,et al.  The dynamic range of protein expression: A challenge for proteomic research , 2000, Electrophoresis.

[75]  S. Gygi,et al.  Quantitative analysis of complex protein mixtures using isotope-coded affinity tags , 1999, Nature Biotechnology.

[76]  C. Weyand,et al.  Pathogenic mechanisms in giant cell arteritis. , 2002, Cleveland Clinic journal of medicine.

[77]  Erkki Ruoslahti,et al.  Organ targeting In vivo using phage display peptide libraries , 1996, Nature.

[78]  J. Lindon,et al.  Metabonomics: a platform for studying drug toxicity and gene function , 2002, Nature Reviews Drug Discovery.

[79]  S. Ye,et al.  Microarray, SAGE and their applications to cardiovascular diseases , 2002, Cell Research.

[80]  A. Gough,et al.  Acute Cardiovascular Toxicity Induced by an Adenosine Agonist-Antihypertensive in Beagles , 1991, Toxicologic pathology.

[81]  C Guijarro,et al.  High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease. , 2001, Circulation.

[82]  M. Nagarkatti,et al.  Growth of FasL-bearing tumor cells in syngeneic murine host induces apoptosis and toxicity in Fas(+) organs. , 2000, Blood.

[83]  G. Schmid-Schönbein,et al.  In vivo evidence for microvascular oxidative stress in spontaneously hypertensive rats. Hydroethidine microfluorography. , 1995, Hypertension.

[84]  John C. Lindon,et al.  Metabonomics: metabolic processes studied by NMR spectroscopy of biofluids , 2000 .

[85]  P. Nambi,et al.  Coronary arterial lesions in dogs treated with an endothelin receptor antagonist. , 1998, Journal of cardiovascular pharmacology.

[86]  G. Orphanides,et al.  Application of genomics to the definition of the molecular basis for toxicity. , 2001, Toxicology letters.

[87]  J. Gauldie,et al.  Acute phase proteins , 1985 .

[88]  E. Topol,et al.  C-reactive protein: a 'golden marker' for inflammation and coronary artery disease. , 2001, Cleveland Clinic journal of medicine.

[89]  R. Cotran.  American Association of Pathologists president's address. New roles for the endothelium in inflammation and immunity. , 1987, The American journal of pathology.

[90]  C. Weyand,et al.  Pathogenic principles in giant cell arteritis. , 2000, International journal of cardiology.

[91]  T. Mak,et al.  Evidence for the involvement of CD44 in endothelial cell injury and induction of vascular leak syndrome by IL-2. , 1999, Journal of immunology.

[92]  K. Büssow,et al.  High-throughput protein arrays: prospects for molecular diagnostics. , 2002, Trends in molecular medicine.

[93]  J. Lindon,et al.  'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. , 1999, Xenobiotica; the fate of foreign compounds in biological systems.

[94]  W. El-Deredy,et al.  Pattern recognition approaches in biomedical and clinical magnetic resonance spectroscopy: a review , 1997, NMR in biomedicine.

[95]  N. Imai,et al.  Effects of Milrinone on Systemic Hemodynamics and Regional Circulations in Dogs with Congestive Heart Failure: Comparison with Dobutamine , 1987, Journal of cardiovascular pharmacology.

[96]  B. Hunt,et al.  Endothelial cell activation in cutaneous vasculitis , 1996, Clinical and experimental dermatology.

[97]  R. Gristwood,et al.  In vivo pharmacological studies with SK&F 94836, a potent inotrope/vasodilator with a sustained duration of action , 1988, British journal of pharmacology.

[98]  M. Chiariello,et al.  Endogenous tissue factor pathway inhibitor modulates thrombus formation in an in vivo model of rabbit carotid artery stenosis and endothelial injury. , 2000, Circulation.

[99]  H. Lum,et al.  Oxidant stress and endothelial cell dysfunction. , 2001, American journal of physiology. Cell physiology.

[100]  L. Ferrer,et al.  Immunohistochemical detection of CD31 antigen in normal and neoplastic canine endothelial cells. , 1995, Journal of comparative pathology.

[101]  T. Lotti,et al.  Cutaneous small-vessel vasculitis. , 1998, Journal of the American Academy of Dermatology.

[102]  M. Higgins,et al.  The Pharmacologic Basis of the Cardiovascular Toxicity of Minoxidil in the Dog , 1995, Toxicologic pathology.

[103]  C. Louden,et al.  Pathology and pathophysiology of drug-induced arterial injury in laboratory animals and its implications on the evaluation of novel chemical entities for human clinical trials. , 2001, Pharmacology & toxicology.

[104]  R. Aebersold,et al.  Advances in proteome analysis by mass spectrometry. , 2001, The Journal of biological chemistry.

[105]  M. Albassam,et al.  Apoptosis and Nitrative Stress Associated with Phosphodiesterase Inhibitor-Induced Mesenteric Vasculitis in Rats , 2003, Toxicologic pathology.

[106]  S. Gygi,et al.  Evaluation of two-dimensional gel electrophoresis-based proteome analysis technology. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[107]  D. Ducharme,et al.  Pathogenesis of Cardiovascular Alterations in Dogs Treated with Minoxidil 1 , 1989, Toxicologic pathology.

[108]  E. Wayner,et al.  Circulating activated endothelial cells in sickle cell anemia. , 1997, The New England journal of medicine.

[109]  S. Schwartz,et al.  Injury induces increase of von Willebrand factor in rat endothelial cells. , 1989, The American journal of pathology.

[110]  A. Blann,et al.  HEMOSTASIS , THROMBOSIS , AND VASCULAR BIOLOGY Direct Evidence of Endothelial Injury in Acute Myocardial Infarction and Unstable Angina by Demonstration of Circulating Endothelial Cells , 1999 .

[111]  M. Momoi,et al.  Elevated serum levels of macrophage colony-stimulating factor in patients with Kawasaki disease complicated by cardiac lesions. , 2001, Clinical and experimental rheumatology.

[112]  B. Coll-Vinent,et al.  Circulating soluble adhesion molecules in patients with classical polyarteritis nodosa. , 1997, British journal of rheumatology.

[113]  M. Albassam,et al.  Arteriopathy Induced by an Adenosine Agonist-Antihypertensive in Monkeys , 1998, Toxicologic pathology.

[114]  G. Russ,et al.  Endothelial cell activation in vasculitis of peripheral nerve and skeletal muscle. , 1992, Journal of neurology, neurosurgery, and psychiatry.

[115]  A. Gearing,et al.  Circulating adhesion molecules in disease. , 1993, Immunology today.

[116]  E. Fung,et al.  ProteinChip clinical proteomics: computational challenges and solutions. , 2002, BioTechniques.

[117]  M. Becker‐André,et al.  Murine endothelial leukocyte-adhesion molecule 1 is a close structural and functional homologue of the human protein. , 1992, European journal of biochemistry.

[118]  P. Bugelski,et al.  Pathogenesis of Arterial Lesions Induced by Dopaminergic Compounds in the Rat 1 , 1989, Toxicologic pathology.

[119]  R. Cotran,et al.  Immunologic interactions of T lymphocytes with vascular endothelium. , 1991, Advances in immunology.

[120]  D. Leung.  The Potential Role of Cytokine‐Mediated Vascular Endothelial Activation in the Pathogenesis of Kawasaki Disease , 1991, Acta paediatrica Japonica : Overseas edition.

[121]  E. Csernok,et al.  ANCA and associated diseases: immunodiagnostic and pathogenetic aspects , 1993, Clinical and experimental immunology.

[122]  M. Reily,et al.  Metabonomic assessment of vasculitis in rats , 2007, Cardiovascular Toxicology.

[123]  Y. Seko.  Takayasu arteritis: insights into immunopathology. , 2000, Japanese heart journal.

[124]  M. Reily,et al.  Metabonomics: evaluation of nuclear magnetic resonance (NMR) and pattern recognition technology for rapid in vivo screening of liver and kidney toxicants. , 2000, Toxicological sciences : an official journal of the Society of Toxicology.

[125]  L. Schwartz,et al.  Evaluation of Plasma von Willebrand Factor as a Biomarker for Acute Arterial Damage in Rats , 2000, Toxicologic pathology.

[126]  C. Font,et al.  Von Willebrand factor in the outcome of temporal arteritis. , 1996, Annals of the rheumatic diseases.

[127]  G. Gray,et al.  The endothelin ETB receptor mediates both vasodilation and vasoconstriction in vivo. , 1992, Biochemical and biophysical research communications.

[128]  L. Requena,et al.  Pathology of Vascular Skin Lesions: Clinicopathologic Correlations , 2003 .

[129]  E. Silverman,et al.  Evidence for RANTES, monocyte chemotactic protein-1, and macrophage inflammatory protein-1 beta expression in Kawasaki disease. , 1997, The Journal of rheumatology.

[130]  Ose,et al.  Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events* , 2002 .

[131]  J. Hirsh,et al.  Endotoxin-induced vascular endothelial injury and repair. II. Focal injury, en face morphology, (3H)thymidine uptake and circulating endothelial cells in the dog. , 1976, Experimental and molecular pathology.

[132]  E. Petricoin,et al.  Toxicoproteomics: Serum Proteomic Pattern Diagnostics for Early Detection of Drug Induced Cardiac Toxicities and Cardioprotection , 2004, Toxicologic pathology.

[133]  S. J. Humphrey,et al.  Whole body and regional hemodynamic effects of minoxidil in the conscious dog. , 1984, Journal of cardiovascular pharmacology.

[134]  N. Barsoum,et al.  Preclinical toxicity studies of an adenosine agonist, N-(2,2-diphenylethyl) adenosine. , 1991, Toxicology.

[135]  C. Rogers,et al.  Vascular disease and injury : preclinical research , 2001 .

[136]  W. Kerns,et al.  Characterization of Coronary Arterial Lesions in the Dog Following Administration of SK&F 95654, a Phosphodiesterase III Inhibitor , 1996, Toxicologic pathology.

[137]  R. Aebersold,et al.  Mass spectrometry in proteomics. , 2001, Chemical reviews.

[138]  E. Fung,et al.  Protein biochips for differential profiling. , 2001, Current opinion in biotechnology.

[139]  H. Sinzinger,et al.  Effect of high and low-dose aspirin on circulating endothelial cells. , 1988, VASA. Zeitschrift fur Gefasskrankheiten.

[140]  G. Groenewegen,et al.  CD44 is involved in tumor angiogenesis; an activation antigen on human endothelial cells. , 1997, Blood.

[141]  T. Hirano,et al.  Induction of rat acute‐phase proteins by interleukin 6 in vivo , 1988, European journal of immunology.

[142]  E. Joseph.  Arterial lesions induced by phosphodiesterase III (PDE III) inhibitors and DA(1) agonists. , 2000, Toxicology letters.

[143]  OlivierFeron,et al.  Hydroxy-Methylglutaryl–Coenzyme A Reductase Inhibition Promotes Endothelial Nitric Oxide Synthase Activation Through a Decrease in Caveolin Abundance , 2001 .

[144]  F. Sánchez‐Madrid,et al.  Cell adhesion molecules: selectins and integrins. , 1999, Critical reviews in immunology.

[145]  P. Cockwell,et al.  Activation of endothelial cells in thrombosis and vasculitis. , 1997, Scandinavian journal of rheumatology.

[146]  T. Shiohara,et al.  Systemic release of interferon-γ in drug-induced cutaneous vasculitis , 1992, The Lancet.

[147]  W. Martin,et al.  Minoxidil: Right Atrial Cardiac Pathology in Animals and in Man , 1980, Circulation.

[148]  D. G. Morgan,et al.  Role of dopaminergic and adrenergic receptors in the pathogenesis of arterial lesions induced by fenoldopam mesylate and dopamine in the rat. , 1989, The American journal of pathology.

[149]  Stephen H. Friend,et al.  Toxicogenomics and drug discovery: will new technologies help us produce better drugs? , 2002, Nature Reviews Drug Discovery.

[150]  F. Dignat-George,et al.  Circulating endothelial cells in vascular disorders: new insights into an old concept , 2000, European journal of haematology.

[151]  R Rubio,et al.  Adenosine and coronary blood flow in conscious dogs during normal physiological stimuli. , 1982, The American journal of physiology.

[152]  R W Glenny,et al.  Validation of fluorescent-labeled microspheres for measurement of regional organ perfusion. , 1993, Journal of applied physiology.

[153]  H. A. Hartman.  Idiopathic Extramural Coronary Arteritis in Beagle and Mongrel Dogs , 1987, Veterinary pathology.

[154]  E Holmes,et al.  Chemometric models for toxicity classification based on NMR spectra of biofluids. , 2000, Chemical research in toxicology.

[155]  D. Vestweber,et al.  Cloning of the mouse endothelial selectins. Expression of both E- and P-selectin is inducible by tumor necrosis factor alpha. , 1992, The Journal of biological chemistry.

[156]  John C. Lindon,et al.  NMR Spectroscopy of Biofluids , 1999 .

[157]  P. Kincade,et al.  CD44 and its interaction with extracellular matrix. , 1993, Advances in immunology.

[158]  M. van der Giessen,et al.  Circulating cytomegalovirus (CMV)-infected endothelial cells in patients with an active CMV infection. , 1993, The Journal of infectious diseases.

[159]  Donna L Mendrick,et al.  Toxicogenomics: a new revolution in drug safety. , 2002, Drug discovery today.

[160]  R. Berne,et al.  Adenosine in the local regulation of blood flow: a brief overview. , 1983, Federation proceedings.

[161]  A. Blann.  Endothelial cell activation, injury, damage and dysfunction: separate entities or mutual terms? , 2000, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[162]  G. Zbinden,et al.  Cardiotoxicity of vasodilators and positive inotropic/vasodilating drugs in dogs: an overview. , 1992, Critical reviews in toxicology.

[163]  Gary L Myers,et al.  Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. , 2003, Circulation.

[164]  P. Snyder,et al.  Interleukin-6 activity in dogs with juvenile polyarteritis syndrome: effect of corticosteroids. , 1995, Clinical immunology and immunopathology.

[165]  V. Tesar,et al.  Influence of Plasma Exchange on Serum Levels of Cytokines and Adhesion Molecules in ANCA-Positive Renal Vasculitis , 1998, Blood Purification.

[166]  A. Inomata,et al.  Coronary arterial lesions induced by endothelin antagonists. , 2000, Toxicology letters.

[167]  J. Loscalzo,et al.  Endothelial cells in physiology and in the pathophysiology of vascular disorders. , 1998, Blood.

[168]  P. Ridker,et al.  High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease. , 2001, Circulation.

[169]  C. Hartley,et al.  Effects of hydralazine on regional blood flow in conscious dogs. , 1986, The Journal of pharmacology and experimental therapeutics.

[170]  Y. Kotelevtsev,et al.  Application of gene expression profiling to cardiovascular disease. , 2002, Cardiovascular research.

[171]  R. Berne.  The role of adenosine in the regulation of coronary blood flow. , 1980, Circulation research.

[172]  G. Hoffman,et al.  Inflammatory Diseases of Blood Vessels , 2001 .

[173]  T. Uchiyama,et al.  The pathogenesis of Kawasaki disease and superantigens. , 1999, Japanese journal of infectious diseases.

[174]  List of drug products that have been withdrawn or removed from the market for reasons of safety or effectiveness. Food and Drug Administration, HHS. Final rule. , 1999, Federal register.

[175]  E Holmes,et al.  Accelerated toxicity screening using NMR and pattern recognition-based methods. , 2000, Current opinion in drug discovery & development.

[176]  Bulbul Chakravarti,et al.  Informatic tools for proteome profiling. , 2002, BioTechniques.

[177]  J. Sobota.  Review of Cardiovascular Findings in Humans Treated with Minoxidil 1 , 1989, Toxicologic pathology.

[178]  J. Ross,et al.  Vascular Gene Discovery Using Laser Capture Microdissection of Human Blood Vessels and Quantitative PCR , 2001, Annals of the New York Academy of Sciences.

[179]  J. Hladovec.  Circulating endothelial cells as a sign of vessel wall lesions. , 1978, Physiologia Bohemoslovaca.

[180]  D. Detweiler,et al.  Spontaneous and Induced Arterial Disease in the Dog: Pathology and Pathogenesis 1 , 1989, Toxicologic pathology.

[181]  D. B. Evans,et al.  The Effect of the Cardiotonic Imazodan (CI‐914) on Myocardial and Peripheral Hemodynamics in the Anesthetized Dog , 1986, Journal of cardiovascular pharmacology.

[182]  C. Dessy,et al.  Hydroxy-Methylglutaryl–Coenzyme A Reductase Inhibition Promotes Endothelial Nitric Oxide Synthase Activation Through a Decrease in Caveolin Abundance , 2001, Circulation.

[183]  I. Pecht,et al.  Mercuric chloride-induced vasculitis in the Brown Norway rat: alpha beta T cell-dependent and -independent phases: role of the mast cell. , 1997, Journal of immunology.

[184]  Harmonization of animal clinical pathology testing in toxicity and safety studies. The Joint Scientific Committee for International Harmonization of Clinical Pathology Testing. , 1996, Fundamental and applied toxicology : official journal of the Society of Toxicology.

[185]  Andreas D. Baxevanis,et al.  Bioinformatics - a practical guide to the analysis of genes and proteins , 2001, Methods of biochemical analysis.

[186]  Vilmundur Gudnason,et al.  C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. , 2004, The New England journal of medicine.

[187]  D. Hochstrasser,et al.  The dynamic range of protein expression: A challenge for proteomic research , 2000, Electrophoresis.

[188]  Erkki Ruoslahti,et al.  Organ targeting In vivo using phage display peptide libraries , 1996, Nature.

[189]  J. Lindon,et al.  Metabonomics: a platform for studying drug toxicity and gene function , 2002, Nature Reviews Drug Discovery.

[190]  G. Schmid-Schönbein,et al.  In vivo evidence for microvascular oxidative stress in spontaneously hypertensive rats. Hydroethidine microfluorography. , 1995, Hypertension.

[191]  John C. Lindon,et al.  Metabonomics: metabolic processes studied by NMR spectroscopy of biofluids , 2000 .

[192]  G. Orphanides,et al.  Application of genomics to the definition of the molecular basis for toxicity. , 2001, Toxicology letters.

[193]  R. Cotran.  American Association of Pathologists president's address. New roles for the endothelium in inflammation and immunity. , 1987, The American journal of pathology.

[194]  K. Büssow,et al.  High-throughput protein arrays: prospects for molecular diagnostics. , 2002, Trends in molecular medicine.

[195]  J. Lindon,et al.  'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. , 1999, Xenobiotica; the fate of foreign compounds in biological systems.

[196]  W. El-Deredy,et al.  Pattern recognition approaches in biomedical and clinical magnetic resonance spectroscopy: a review , 1997, NMR in biomedicine.

[197]  N. Imai,et al.  Effects of Milrinone on Systemic Hemodynamics and Regional Circulations in Dogs with Congestive Heart Failure: Comparison with Dobutamine , 1987, Journal of cardiovascular pharmacology.

[198]  B. Hunt,et al.  Endothelial cell activation in cutaneous vasculitis , 1996, Clinical and experimental dermatology.

[199]  R. Gristwood,et al.  In vivo pharmacological studies with SK&F 94836, a potent inotrope/vasodilator with a sustained duration of action , 1988, British journal of pharmacology.

[200]  H. Lum,et al.  Oxidant stress and endothelial cell dysfunction. , 2001, American journal of physiology. Cell physiology.

[201]  L. Ferrer,et al.  Immunohistochemical detection of CD31 antigen in normal and neoplastic canine endothelial cells. , 1995, Journal of comparative pathology.

[202]  T. Lotti,et al.  Cutaneous small-vessel vasculitis. , 1998, Journal of the American Academy of Dermatology.

[203]  C. Louden,et al.  Pathology and pathophysiology of drug-induced arterial injury in laboratory animals and its implications on the evaluation of novel chemical entities for human clinical trials. , 2001, Pharmacology & toxicology.

[204]  R. Aebersold,et al.  Advances in proteome analysis by mass spectrometry. , 2001, The Journal of biological chemistry.

[205]  M. Albassam,et al.  Apoptosis and Nitrative Stress Associated with Phosphodiesterase Inhibitor-Induced Mesenteric Vasculitis in Rats , 2003, Toxicologic pathology.

[206]  E. Wayner,et al.  Circulating activated endothelial cells in sickle cell anemia. , 1997, The New England journal of medicine.

[207]  S. Schwartz,et al.  Injury induces increase of von Willebrand factor in rat endothelial cells. , 1989, The American journal of pathology.

[208]  B. Coll-Vinent,et al.  Circulating soluble adhesion molecules in patients with classical polyarteritis nodosa. , 1997, British journal of rheumatology.

[209]  G. Russ,et al.  Endothelial cell activation in vasculitis of peripheral nerve and skeletal muscle. , 1992, Journal of neurology, neurosurgery, and psychiatry.

[210]  A. Gearing,et al.  Circulating adhesion molecules in disease. , 1993, Immunology today.

[211]  E. Fung,et al.  ProteinChip clinical proteomics: computational challenges and solutions. , 2002, BioTechniques.

[212]  M. Becker‐André,et al.  Murine endothelial leukocyte-adhesion molecule 1 is a close structural and functional homologue of the human protein. , 1992, European journal of biochemistry.

[213]  E. Csernok,et al.  ANCA and associated diseases: immunodiagnostic and pathogenetic aspects , 1993, Clinical and experimental immunology.

[214]  G. Gray,et al.  The endothelin ETB receptor mediates both vasodilation and vasoconstriction in vivo. , 1992, Biochemical and biophysical research communications.

[215]  Ose,et al.  Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events* , 2002 .

[216]  S. J. Humphrey,et al.  Whole body and regional hemodynamic effects of minoxidil in the conscious dog. , 1984, Journal of cardiovascular pharmacology.

[217]  N. Barsoum,et al.  Preclinical toxicity studies of an adenosine agonist, N-(2,2-diphenylethyl) adenosine. , 1991, Toxicology.

[218]  W. Son.  Idiopathic canine polyarteritis in control beagle dogs from toxicity studies. , 2004, Journal of veterinary science.

[219]  C. Rogers,et al.  Vascular disease and injury : preclinical research , 2001 .

[220]  E. Fung,et al.  Protein biochips for differential profiling. , 2001, Current opinion in biotechnology.

[221]  H. Sinzinger,et al.  Effect of high and low-dose aspirin on circulating endothelial cells. , 1988, VASA. Zeitschrift fur Gefasskrankheiten.

[222]  T. Hirano,et al.  Induction of rat acute‐phase proteins by interleukin 6 in vivo , 1988, European journal of immunology.

[223]  F. Sánchez‐Madrid,et al.  Cell adhesion molecules: selectins and integrins. , 1999, Critical reviews in immunology.

[224]  P. Cockwell,et al.  Activation of endothelial cells in thrombosis and vasculitis. , 1997, Scandinavian journal of rheumatology.

[225]  W. Martin,et al.  Minoxidil: Right Atrial Cardiac Pathology in Animals and in Man , 1980, Circulation.

[226]  Stephen H. Friend,et al.  Toxicogenomics and drug discovery: will new technologies help us produce better drugs? , 2002, Nature Reviews Drug Discovery.

[227]  F. Dignat-George,et al.  Circulating endothelial cells in vascular disorders: new insights into an old concept , 2000, European journal of haematology.

[228]  R Rubio,et al.  Adenosine and coronary blood flow in conscious dogs during normal physiological stimuli. , 1982, The American journal of physiology.

[229]  R W Glenny,et al.  Validation of fluorescent-labeled microspheres for measurement of regional organ perfusion. , 1993, Journal of applied physiology.

[230]  H. A. Hartman.  Idiopathic Extramural Coronary Arteritis in Beagle and Mongrel Dogs , 1987, Veterinary pathology.